The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease

Annals of Pharmacotherapy

Volumn 31, Issue 7-8, 1997, Pages 907-913

  Bonapace, Charles R ^a   Mays, David A ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b University of Maryland ^*  (United States)

Author keywords

Crohn's disease; Mesalamine; Nicotine; Ulcerative colitis

Indexed keywords

MESALAZINE; NICOTINE; SALAZOSULFAPYRIDINE; STEROID;

ARTICLE; CROHN DISEASE; DOSE RESPONSE; ENTERITIS; PRIORITY JOURNAL; RELAPSE; REMISSION; TRANSDERMAL DRUG ADMINISTRATION; ULCERATIVE COLITIS;

EID: 0030749161     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100719     Document Type: Article

References (32)

1. Segars LW, Gales BJ. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease. Clin Pharm 1992;11:514-28.
2. Cotran RS, Kumar V, Robbins SL. Robbins pathologic basis of disease. 4th rev ed. Philadelphia: WB Saunders Co., 1989.
3. Azad-Khan AK, Piris J, Truelove SC. An experiment to determine the active moiety of sulphasalazine. Lancet 1977;2:892-5.
4. Peppercorn MA, Goldman P. Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology 1973;64:240-5.
5. Ryan K, Bottom C, Cameron C, Payne P, Guernsey B. Effects of pH on dissolution of various mesalamine (5-ASA) dosage forms (abstract). Gastroenterology 1988;94(no. 5, pt 2):A391.
6. Rhodes J, Thomas G. Nicotine treatment in ulcerative colitis. Drugs 1995;49:157-60.
7. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-54.
8. Lindberg E, Tysk C, Andersson K, Jarnerot G. Smoking and inflammatory bowel disease; a case-control study. Gut 1988;29:352-7.
9. Motley RJ, Rhodes J, Kay S, Morris TJ. Late presentation of ulcerative colitis in ex-smokers. Int J Colorectal Dis 1988;3:171-5.
10. Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soule JC, et al., the Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. Gastroenterology 1993;104:435-9.
11. Singleton J, Gitnik G, Hanauer S, Krawitt E, Robinson M, Roufail W, et al., Pentasa Study Group. Response of Crohn's disease to oral Pentasa (controlled-release mesalamine) as a function of disease location and prior therapy: results of a multicenter study (abstract). Gastroenterology 1991;100:A251.
12. Sutherland LR, Martin F, Baily RJ, Fedorak R, Dallaire C, Rossman R, et al. 5-Aminosalicylic acid (Pentasa) in the maintenance of remission of Crohn's disease (abstract). Gastroenterology 1995;108(suppl 4):A924.
13. Munkholm P, Binder V, Langholz E, Davidsen M. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994;35: 360-2.
14. Landi B, N'guyen A, Cortot A, Soute JC, Rene E, Gendre JP, et al., the Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Endoscopic monitoring of Crohn's disease: a prospective, randomized clinical trial. Gastroenterology 1992;102:1647-53.
15. Brignola C, De Simone G, Belloi C, Iannone A, Belluzzi A, Gionchetti P, et al. Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration. Aliment Pharmacol Ther 1994;8:465-8.
16. Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, et al., the Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance. Gastroenterology 1996;110:688-93.
17. Brignola C, Cottone M, Pera A, Adrizzone S, Scribano ML, De Franchis R, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology 1995;108:345-9.
18. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualized ileal ulcers preceding symptoms. Gut 1992;33:331-5.
19. Singleton, JW, Hanauer SB, Bitnick GL, Peppercorn MA, Wruble LW, Krawitt EL, et al. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Gastroenterology 1993;104: 1293-301.
20. Hanauer S, Schwartz J, Robinson M, Roufail W, Arora S, Cello J, et al. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Am J Gastroenterol 1993;88:1188-97.
21. Miner P, Nostrant T, Wruble L, Hines C, Johnson S, Wilkinson C, et al. Multicenter trial of Pentasa for active ulcerative colitis (abstract). Gastroenterology 1991;100:A231.
22. Sninsky CA, Cort DH, Shanahon F, Powers BJ, Sessions JT, Pruitt RE, et al. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. Ann Intern Med 1990;115:350-5.
23. Biddle WL, Miner PB. Long-term use of mesalamine enemas to induce remission in ulcerative colitis. Gastroenterology 1990;99:113-8.
24. Hanauer SB, Kane SV, Guernsey B, O'Connor T, Robinson M, Peppercorn M, et al. Randomized clinical trial of mesalamine (5-ASA) enemas in distal ulcerative colitis: a dose-ranging placebo controlled study (abstract). Gastroenterology 1989;96:A195.
25. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955;2:1041-8.
26. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330:811-5.
27. Motley RJ, Rhodes J, Kay S, Morris TJ. Late presentation of ulcerative colitis in ex-smokers. Int J Colorectal Dis 1988;3:171-5.
28. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1984;19:824-30.
29. Benoni C, Nilsson A, Nivod O. Smoking habits in patients with inflammatory bowel disease: a case-control study. Scand J Gastroenterol 1987; 22:1130-6.
30. Srivastava ED, Newcombe RG, Rhodes J, Avramidis P, Mayberry JF. Smoking and ulcerative colitis: a community study. Int J Colorectal Dis 1993;8:71-4.
31. Thomas GAO, Rhodes J, Mani V, Williams GT, Newcombe RG, Russell MAH, et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995;332:989-92.
32. Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994;106:643-8.